Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen N Davis

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Journal of Diabetes and Its Complications|November 9, 2004
The role of glimepiride in the effective management of Type 2 diabetesStephen N Davis
Journal of Diabetes and Its Complications|April 17, 2008
The role of inhaled insulin in the treatment of type 2 diabetesStephen N Davis
Nature Reviews. Endocrinology|May 16, 2009
Diabetes: Hypoglycemia-a new approach to an old problemStephen N Davis
Journal of Managed Care Pharmacy : JMCP|May 6, 2006
Contemporary strategies for managing cardiometabolic risk factorsStephen N Davis
Expert Review of Clinical Pharmacology|December 7, 2013
Canagliflozin versus glimepiride treatment in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU trial)Stephen N Davis
Diabetes Care|January 30, 2002
Caffeine: a cause of insulin resistance?Italo Biaggioni, Stephen N Davis
Expert Opinion on Drug Metabolism & Toxicology|May 11, 2016
Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitusRana Malek, Stephen N Davis
Expert Review of Clinical Pharmacology|May 21, 2021
Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndromeMaka Siamashvili, Stephen N Davis
Expert Opinion on Pharmacotherapy|December 4, 2024
Evaluating semaglutide + LAI-287 (IcoSema) for the treatment of diabetes mellitus type IIMaka Siamashvili, Stephen N Davis
Expert Opinion on Investigational Drugs|January 15, 2016
Tyrosine kinase inhibitors under investigation for the treatment of type II diabetesRana Malek, Stephen N Davis
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Journal of Diabetes and Its Complications|November 9, 2004
The role of glimepiride in the effective management of Type 2 diabetesStephen N Davis
Journal of Diabetes and Its Complications|April 17, 2008
The role of inhaled insulin in the treatment of type 2 diabetesStephen N Davis
Nature Reviews. Endocrinology|May 16, 2009
Diabetes: Hypoglycemia-a new approach to an old problemStephen N Davis
Journal of Managed Care Pharmacy : JMCP|May 6, 2006
Contemporary strategies for managing cardiometabolic risk factorsStephen N Davis
Expert Review of Clinical Pharmacology|December 7, 2013
Canagliflozin versus glimepiride treatment in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU trial)Stephen N Davis
Diabetes Care|January 30, 2002
Caffeine: a cause of insulin resistance?Italo Biaggioni, Stephen N Davis
Expert Opinion on Drug Metabolism & Toxicology|May 11, 2016
Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitusRana Malek, Stephen N Davis
Expert Review of Clinical Pharmacology|May 21, 2021
Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndromeMaka Siamashvili, Stephen N Davis
Expert Opinion on Pharmacotherapy|December 4, 2024
Evaluating semaglutide + LAI-287 (IcoSema) for the treatment of diabetes mellitus type IIMaka Siamashvili, Stephen N Davis
Expert Opinion on Investigational Drugs|January 15, 2016
Tyrosine kinase inhibitors under investigation for the treatment of type II diabetesRana Malek, Stephen N Davis
Pageof 13